Management of Pulmonary Arterial Hypertension Crisis

Immediate Recognition and ICU Admission

The European Society of Cardiology recommends hospitalization in the ICU for PAH patients presenting with high heart rate, low systolic blood pressure, low urine output, and rising lactate levels, indicating imminent right ventricular failure and requiring immediate intervention 1, 2
The mortality rate for PAH patients admitted to the ICU ranges from 41%, underscoring the critical nature of these events and the need for management at specialized centers whenever possible 1

Basic monitoring must include vital signs, urine production, central venous pressure, central venous oxygen saturation, and blood lactate levels, according to the European Heart Journal 1
The combination of central venous oxygen saturation <60% with rising lactate levels and absent urine production signals imminent right heart failure requiring escalation of therapy 1
The critical goal is maintaining systemic vascular resistance greater than pulmonary vascular resistance at all times, as recommended by the European Heart Journal 3

Inhaled nitric oxide is the preferred first-line pulmonary vasodilator for acute PAH crisis because it decreases pulmonary vascular resistance, improves cardiac output, has a short half-life allowing rapid titration, and does not affect systemic vascular resistance, according to the European Heart Journal 3
If inhaled nitric oxide is unavailable or the patient requires escalation, continuous IV epoprostenol should be initiated immediately, starting at 2 ng/kg/min and increasing in increments of 2 ng/kg/min every 15 minutes or longer until dose-limiting effects occur or tolerance is established, as recommended by the European Heart Journal 2
IV epoprostenol has demonstrated mortality reduction in high-risk PAH patients, according to the European Heart Journal 2

Dobutamine is the preferred inotrope for right ventricular failure in PAH crisis because it has neutral or beneficial effects on pulmonary vascular resistance and a shorter half-life than milrinone, allowing better control when hypotension risk exists, as recommended by the European Heart Journal 1, 3
Inotropic support is recommended in all hypotensive patients to maintain adequate cardiac output and systemic perfusion, according to the European Heart Journal 2

Treatment of triggering factors includes optimization of fluid balance, usually with IV diuretics, as volume overload worsens right ventricular function, as recommended by the European Heart Journal 1
Aggressive volume expansion must be avoided in patients with right ventricular failure, according to the European Heart Journal 3

Maintain oxygen saturation >90% at all times to prevent hypoxia-induced increases in pulmonary vascular resistance, as recommended by the European Heart Journal 3
If mechanical ventilation becomes necessary, use low tidal volume strategy to minimize increases in right ventricular afterload, keep peak pressures <30 cmH₂O, limit positive end-expiratory pressure to ≤10 cmH₂O when possible, and avoid permissive hypercapnia as acidosis acutely increases pulmonary vascular resistance, according to the European Heart Journal 3

For patients with PAH crisis, low cardiac output, or right ventricular failure despite optimal medical therapy, veno-arterial ECMO should be considered as a bridge to recovery or transplantation, as recommended by the European Heart Journal 1, 2, 3

All PAH patients must be admitted to the ICU/CCU for at least 24 hours of monitoring after stabilization, as major cardiovascular complications often manifest 1-2 days following the acute event, according to the European Heart Journal and Circulation Research 1, 4